MoonLake Obtains $500 Million Facility From Hercules Capital

Important legal information about the email you will be sending. By using this service, you agree to input your real email address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an email. All information you provide will be used by Fidelity solely for the purpose of sending the email on your behalf. The subject line of the email you send will be "Fidelity.com: "

MoonLake Obtains $500 Million Facility From Hercules Capital

, MT Newswires - 7:55 AM ET 4/3/2025 default

07:55 AM EDT, 04/03/2025 (MT Newswires) -- MoonLake Immunotherapeutics ( MLTX ) said Thursday it entered into an agreement for a facility of up to $500 million from Hercules Capital ( HTGC ) .

MoonLake said that $75 million was drawn down at the transaction's close and that additional tranches will become available upon the company achieving certain milestones.

The company said the additional capital will support the expected launch of sonelokimab in 2027, additional clinical trials, and further investments for growth.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.